Medicare Enrolled
Dr. Kaleem Ahmad, M.D.
Hematology & Oncology · Marmora, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ahmad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahmad
Dr. Kaleem Ahmad is a hematology & oncology specialist in Marmora, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ahmad performed 80,345 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ahmad received a total of $13,782 from 104 pharmaceutical and/or device companies across 839 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in NJ
$13,782 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗80,345
Medicare services
Top 13% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
18,420 | $1 | $3 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
11,800 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 9,360 | $1 | $8 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
9,020 | $6 | $27 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
8,700 | $6 | $51 |
| Iron infusion (Monoferric) | 6,200 | $17 | $65 |
| Denosumab injection (Prolia/Xgeva) | 4,860 | $18 | $60 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,907 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,858 | $8 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,725 | $8 | $18 |
| Injection, granisetron hydrochloride, 100 mcg | 1,410 | $0 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
767 | $100 | $231 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
607 | $12 | $81 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
428 | $108 | $833 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
400 | $25 | $128 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $71 | $153 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
286 | $115 | $576 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
264 | $1 | $13 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
252 | $13 | $92 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
201 | $53 | $249 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
158 | $25 | $110 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
157 | $1 | $5 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
142 | $65 | $158 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
126 | $143 | $312 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
123 | $18 | $60 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
106 | $1 | $14 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
87 | $60 | $195 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
84 | $4 | $24 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
81 | $41 | $110 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
78 | $145 | $424 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
68 | $17 | $73 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
66 | $57 | $272 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
45 | $74 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $124 | $351 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
37 | $8 | $33 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
35 | $18 | $92 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $99 | $232 |
| New patient office visit, complex (60-74 min) | 22 | $170 | $446 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $108 | $297 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.0% high complexity
83.7% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,782
Total received (2018-2024)
Avg $1,969/year across 7 years
Top 22% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
104
Companies
839
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,221
2023
$2,307
2022
$2,075
2021
$1,522
2020
$1,378
2019
$2,152
2018
$2,127
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$173
Merck Sharp & Dohme LLC
$172
AstraZeneca Pharmaceuticals LP
$136
Janssen Biotech, Inc.
$104
Incyte Corporation
$96
Lilly USA, LLC
$85
Acrotech Biopharma Inc.
$84
PUMA BIOTECHNOLOGY, INC.
$81
Tempus AI, Inc
$79
Eisai Inc.
$77
Daiichi Sankyo Inc.
$76
PFIZER INC.
$74
GlaxoSmithKline, LLC.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$69
Mirati Therapeutics, Inc.
$62
Bayer Healthcare Pharmaceuticals Inc.
$56
E.R. Squibb & Sons, L.L.C.
$50
Celgene Corporation
$48
Astellas Pharma US Inc
$47
Kite Pharma, Inc.
$44
Spectrum Pharmaceuticals Inc.
$44
Genmab U.S., Inc.
$40
Aveo Pharmaceuticals, Inc.
$36
SERVIER PHARMACEUTICALS LLC
$36
Adaptive Biotechnologies Corporation
$35
SOBI, INC
$34
Genentech USA, Inc.
$34
ABBVIE INC.
$32
Fresenius Kabi USA, LLC
$23
ADC Therapeutics America, Inc.
$19
Stemline Therapeutics Inc.
$18
TerSera Therapeutics LLC
$18
Regeneron Healthcare Solutions, Inc.
$18
EMD Serono, Inc.
$18
Pharmacosmos Therapeutics Inc.
$16
Gilead Sciences, Inc.
$16
TAIHO ONCOLOGY, INC.
$16
SpringWorks Therapeutics, Inc.
$16
Kyowa Kirin, Inc.
$15
Sumitomo Pharma America, Inc.
$15
ARRAY BIOPHARMA INC
$15
Exelixis Inc.
$15
Blueprint Medicines Corporation
$14
Top 3 companies account for 21.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$904
Novartis Pharmaceuticals Corporation
$896
Incyte Corporation
$712
AstraZeneca Pharmaceuticals LP
$693
Merck Sharp & Dohme LLC
$536
PFIZER INC.
$531
Lilly USA, LLC
$511
Janssen Biotech, Inc.
$476
Amgen Inc.
$426
Genentech USA, Inc.
$407
Seagen Inc.
$404
Takeda Pharmaceuticals U.S.A., Inc.
$398
Merck Sharp & Dohme Corporation
$385
Celgene Corporation
$356
Daiichi Sankyo Inc.
$326
Bayer HealthCare Pharmaceuticals Inc.
$288
Eisai Inc.
$274
Pharmacyclics LLC, An AbbVie Company
$253
GENZYME CORPORATION
$241
Astellas Pharma US Inc
$222
TESARO, Inc.
$207
AVEO Pharmaceuticals, Inc.
$196
EISAI INC.
$168
Acrotech Biopharma Inc.
$161
PUMA BIOTECHNOLOGY, INC.
$144
Gilead Sciences, Inc.
$136
GlaxoSmithKline, LLC.
$127
Exelixis Inc.
$121
Rigel Pharmaceuticals, Inc.
$121
AMAG Pharmaceuticals, Inc.
$114
Pharmacosmos Therapeutics Inc.
$106
ARRAY BIOPHARMA INC
$98
Kite Pharma, Inc.
$95
Bayer Healthcare Pharmaceuticals Inc.
$93
Dova Pharmaceuticals
$92
MorphoSys, US Inc.
$85
Seattle Genetics, Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
Regeneron Healthcare Solutions, Inc.
$83
Acrotech Biopharma LLC
$83
Foundation Medicine, Inc.
$81
Mirati Therapeutics, Inc.
$80
Tempus AI, Inc
$79
SERVIER PHARMACEUTICALS LLC
$75
SOBI, INC
$75
Taiho Oncology, Inc.
$70
Epizyme, Inc.,
$68
Puma Biotechnology, Inc.
$60
Alexion Pharmaceuticals, Inc.
$59
Ipsen Biopharmaceuticals, Inc
$59
Adaptive Biotechnologies Corporation
$58
Genmab U.S., Inc.
$56
NanoString Technologies, Inc.
$51
Sirtex Medical Inc
$50
Pharmacyclics LLC, an AbbVie Company
$49
TerSera Therapeutics LLC
$48
Aurobindo Pharma USA, Inc.
$47
BeiGene USA, Inc.
$46
Karyopharm Therapeutics Inc.
$46
Spectrum Pharmaceuticals Inc.
$44
Fresenius Kabi USA, LLC
$39
Clovis Oncology, Inc.
$39
Aveo Pharmaceuticals, Inc.
$36
Stemline Therapeutics Inc.
$34
ABBVIE INC.
$32
Kyowa Kirin, Inc.
$32
JAZZ PHARMACEUTICALS INC.
$32
Blueprint Medicines Corporation
$31
Janssen Pharmaceuticals, Inc
$30
AbbVie Inc.
$29
TAIHO ONCOLOGY, INC.
$28
Coherus Biosciences Inc.
$28
Verastem, Inc.
$27
Lexicon Pharmaceuticals, Inc.
$26
Acceleron Pharma, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$26
Sysmex Inostics Inc
$23
Heron Therapeutics, Inc.
$22
Prometheus Laboratories Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Immunomedics, Inc.
$21
Octapharma USA, Inc.
$21
EUSA Pharma (US) LLC
$20
ADC Therapeutics America, Inc.
$19
EMD Serono, Inc.
$18
SpringWorks Therapeutics, Inc.
$16
Sumitomo Pharma America, Inc.
$15
Sobi, Inc
$15
Global Blood Therapeutics, Inc.
$15
Jazz Pharmaceuticals Inc.
$15
AbbVie, Inc.
$15
Shire North American Group Inc
$14
Mylan Institutional Inc.
$14
Deciphera Pharmaceuticals Inc.
$14
Advanced Accelerator Applications
$14
Bio Products Laboratory USA, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Secura Bio, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
SANOFI-AVENTIS U.S. LLC
$13
Servier Pharmaceuticals LLC
$12
Myovant Sciences Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$10
Top 3 companies account for 18.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · Cabometyx · Coagadex · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FARYDAK · FASLODEX · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Marqibo · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Pomalyst · Poteligeo · Proleukin · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stimufend · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Tivdak · Trodelvy · Udenyca · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VONJO · VPRIV · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
13
County median income
$88,046
Nearest hospital to ZIP centroid (approximate)
SHORE MEDICAL CENTER
4.5 mi
4.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ahmad is a mixed practice specialist, with above-average Medicare volume (top 13% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmad experienced with filgrastim injection, 1 microgram?
Based on Medicare claims data, Dr. Ahmad performed 18,420 filgrastim injection, 1 microgram services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ahmad receive payments from pharmaceutical companies?
Yes. Dr. Ahmad received a total of $13,782 from 104 companies across 839 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmad's costs compare to other hematology & oncology specialists in Marmora?
Dr. Ahmad's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Marmora
Browse hematology & oncology specialists in Marmora ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology